09.27.10
Sweden-based BioGaia and SCA have signed a long-term collaboration agreement for the purpose of developing new health-targeted products through BioGaia’s probiotic bacteria and application technologies combined with SCA’s competence in the field of hygiene products. The objective is to develop products specifically suited to the companies’ distribution networks.
BioGaia’s task will be to match different patented strains with different indications, test these in clinical trials and to create formulations that are specially adapted to the indication. SCA will offer patented technologies in the area of hygiene and an extensive distribution network where probiotics can be marketed and sold. The areas of interest are intimate hygiene products and products for the elderly.
BioGaia’s task will be to match different patented strains with different indications, test these in clinical trials and to create formulations that are specially adapted to the indication. SCA will offer patented technologies in the area of hygiene and an extensive distribution network where probiotics can be marketed and sold. The areas of interest are intimate hygiene products and products for the elderly.
